10x Genomics Inc (TXG)
27.48
+1.19
(+4.53%)
USD |
NASDAQ |
May 03, 16:00
27.46
-0.02
(-0.05%)
After-Hours: 20:00
10x Genomics Enterprise Value: 2.918B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.918B |
| May 02, 2024 | 2.775B |
| May 01, 2024 | 2.851B |
| April 30, 2024 | 3.133B |
| April 29, 2024 | 3.028B |
| April 26, 2024 | 2.931B |
| April 25, 2024 | 2.848B |
| April 24, 2024 | 2.923B |
| April 23, 2024 | 2.930B |
| April 22, 2024 | 2.956B |
| April 19, 2024 | 2.973B |
| April 18, 2024 | 3.094B |
| April 17, 2024 | 3.119B |
| April 16, 2024 | 3.315B |
| April 15, 2024 | 3.562B |
| April 12, 2024 | 3.764B |
| April 11, 2024 | 3.979B |
| April 10, 2024 | 3.855B |
| April 09, 2024 | 4.101B |
| April 08, 2024 | 3.997B |
| April 05, 2024 | 3.967B |
| April 04, 2024 | 3.906B |
| April 03, 2024 | 3.979B |
| April 02, 2024 | 3.951B |
| April 01, 2024 | 4.063B |
| Date | Value |
|---|---|
| March 31, 2024 | 4.121B |
| March 28, 2024 | 4.084B |
| March 27, 2024 | 4.007B |
| March 26, 2024 | 3.931B |
| March 25, 2024 | 3.938B |
| March 22, 2024 | 3.936B |
| March 21, 2024 | 4.140B |
| March 20, 2024 | 4.090B |
| March 19, 2024 | 4.072B |
| March 18, 2024 | 3.911B |
| March 15, 2024 | 3.941B |
| March 14, 2024 | 4.047B |
| March 13, 2024 | 4.202B |
| March 12, 2024 | 4.279B |
| March 11, 2024 | 4.418B |
| March 08, 2024 | 4.355B |
| March 07, 2024 | 4.494B |
| March 06, 2024 | 4.534B |
| March 05, 2024 | 4.790B |
| March 04, 2024 | 4.949B |
| March 01, 2024 | 5.041B |
| February 29, 2024 | 5.169B |
| February 28, 2024 | 5.175B |
| February 27, 2024 | 5.231B |
| February 26, 2024 | 5.027B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.340B
Minimum
Oct 24 2022
21.50B
Maximum
Jun 23 2021
9.003B
Average
6.306B
Median
Dec 18 2019
Enterprise Value Benchmarks
| Teladoc Health Inc | 2.609B |
| American Shared Hospital Services | 26.35M |
| Novo Integrated Sciences Inc | 12.29M |
| Astrana Health Inc | 1.458B |
| Cryo-Cell International Inc | 81.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -59.95M |
| Revenue (Quarterly) | 141.01M |
| Total Expenses (Quarterly) | 202.50M |
| EPS Diluted (Quarterly) | -0.50 |
| Gross Profit Margin (Quarterly) | 65.89% |
| Profit Margin (Quarterly) | -42.52% |
| Earnings Yield | -8.12% |
| Normalized Earnings Yield | -8.115 |